Abstract
Recurrent chromosomal gains at 1q, 6p, 8q, and 17q, or losses at 1p, 4q, 6q, 8p, 9p, 13q, 16q, and 17p are common features of human hepatocellular carcinoma (HCC). For precise determination of the shortest region of overlap (SRO), 49 HCC obtained at the time of surgery or autopsy were subjected to comprehensive microsatellite analysis by using 400 markers distributed at almost equal distances throughout the 22 autosomes and X chromosomes. Each allele showing imbalance was subjected to comparative duplex polymerase chain reaction using a retained allele as an internal control to determine whether the imbalance was the result of chromosomal gain or loss. The following SRO of recurrent chromosomal gains and losses were determined: −1p36.22∼p36.33, D1S450-D1S2893, 5.0 mega–base pairs (Mbp); +1q23.3∼q25.3, D1S2878-D1S2619, 16.9 Mbp; −4q21.2∼q24, D4S2964-D4S1572, 23.0 Mbp; −6q23.3∼qter, D6S292-qter, 34.7 Mb; −8p22∼p23.1, D8S549-D8S550, 4.8 Mbp; +8q12.2∼q24.13, D8S260-D8S514, 61.8 Mbp; −13q13.3∼q22.1, D13S218-D13S156, 35.6 Mbp; −16q22.1∼qter, D16S503-qter, 26.7 Mbp; and −17p12∼pter, D17S921-pter, 14.2 Mbp. Contrary to our initial expectations, many HCC showed major deletions or additions of chromosome arms, so that a number of genes were included in the SRO. Although some putative oncogenes or tumor suppressor genes mapped in these SRO may be important, relative copy number changes of numerous other genes may affect pathogenesis of HCC.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.